Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://specialty.mims.com/topic/novel-bispecific-antibody-exudes-promise-for-relapsed-refractory-dlbcl
0
0
Novel bispecific antibody exudes promise for relapsed/refractory DLBCL | Latest news for Doctors, Nurses and Pharmacists | Pharmacy - MIMS
2/20/23 at 2:00am
Organization
Mims.com
Author
Audrey Abella
Details
44 words
Summarize
Business & Industrial
Drugs & Medications
bispecific antibody
DLBCL
bispecific antibody glofitamab
In a phase I/II study, the novel T-cell-engaging bispecific antibody glofitamab bares its potential for relapsed or refractory diffuse large B-cell ly...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...